Literature DB >> 1431960

Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles.

U M Mann1, E Mohr, M Gearing, T N Chase.   

Abstract

In an attempt to define possible subgroups of Alzheimer's disease, 21 patients satisfying current clinical diagnostic criteria for this disorder were divided on the basis of progression rates of symptoms. Thirteen patients with relatively rapid intellectual deterioration did not differ from eight patients showing slow progression with respect to global intellectual performance, sex, or age at onset of symptoms. Neuropsychological testing revealed that although the two groups were indistinguishable in verbal or visuospatial functions associated with the parietotemporal cortex, the more rapidly deteriorating group had significantly greater impairment in executive functions attributed to the frontal lobe. PET scans showed equivalent reductions in glucose metabolism in the parietotemporal cortex, but patients with relatively fast progression had significantly greater hypometabolism frontally. These results suggest an association between relatively severe frontal lobe involvement and a rapid clinical course that might have important implications for the development of treatment strategies for patients with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431960      PMCID: PMC1015199          DOI: 10.1136/jnnp.55.10.956

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  24 in total

1.  A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer's disease.

Authors:  G S Zubenko; J Moossy; A J Martinez; G R Rao; U Kopp; I Hanin
Journal:  Arch Neurol       Date:  1989-06

2.  Clinical heterogeneity in senile dementia.

Authors:  C McDonald
Journal:  Br J Psychiatry       Date:  1969-03       Impact factor: 9.319

3.  Age and histopathologic heterogeneity in Alzheimer's disease. Evidence for subtypes.

Authors:  W Bondareff; C Q Mountjoy; M Roth; M N Rossor; L L Iversen; G P Reynolds
Journal:  Arch Gen Psychiatry       Date:  1987-05

4.  Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations.

Authors:  D P Salmon; L J Thal; N Butters; W C Heindel
Journal:  Neurology       Date:  1990-08       Impact factor: 9.910

5.  Working memory and secondary memory deficits in Alzheimer's disease.

Authors:  J T Becker
Journal:  J Clin Exp Neuropsychol       Date:  1988-12       Impact factor: 2.475

6.  Alzheimer's disease: focal cortical changes shown by positron emission tomography.

Authors:  N L Foster; T N Chase; P Fedio; N J Patronas; R A Brooks; G Di Chiro
Journal:  Neurology       Date:  1983-08       Impact factor: 9.910

7.  Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.

Authors:  R P Friedland; T F Budinger; E Koss; B A Ober
Journal:  Neurosci Lett       Date:  1985-02-04       Impact factor: 3.046

8.  Towards a behavioral typology of Alzheimer's patients.

Authors:  A Martin; P Brouwers; F Lalonde; C Cox; P Teleska; P Fedio; N L Foster; T N Chase
Journal:  J Clin Exp Neuropsychol       Date:  1986-10       Impact factor: 2.475

9.  A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two?

Authors:  B Seltzer; I Sherwin
Journal:  Arch Neurol       Date:  1983-03

10.  Dementia: characteristics of a referral population and factors associated with progression.

Authors:  L J Thal; M Grundman; M R Klauber
Journal:  Neurology       Date:  1988-07       Impact factor: 9.910

View more
  18 in total

1.  Executive dysfunction in Alzheimer disease.

Authors:  Margaret M Swanberg; Rochelle E Tractenberg; Richard Mohs; Leon J Thal; Jeffrey L Cummings
Journal:  Arch Neurol       Date:  2004-04

2.  Alzheimer's disease: rapid and slow progression.

Authors:  Craig J Thalhauser; Natalia L Komarova
Journal:  J R Soc Interface       Date:  2011-06-08       Impact factor: 4.118

3.  Genetic determinants of disease progression in Alzheimer's disease.

Authors:  Xingbin Wang; Oscar L Lopez; Robert A Sweet; James T Becker; Steven T DeKosky; Mahmud M Barmada; F Yesim Demirci; M Ilyas Kamboh
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Differential Contributions of Selective Attention and Sensory Integration to Driving Performance in Healthy Aging and Alzheimer's Disease.

Authors:  Umesh M Venkatesan; Elena K Festa; Brian R Ott; William C Heindel
Journal:  J Int Neuropsychol Soc       Date:  2017-12-28       Impact factor: 2.892

Review 5.  Diagnostic confirmation, severity, and subtypes of Alzheimer's disease. A short review on clinico-pathological correlations.

Authors:  H Förstl; P Fischer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

6.  Verbal fluency predicts mortality in Alzheimer disease.

Authors:  Stephanie Cosentino; Nikolaos Scarmeas; Steven M Albert; Yaakov Stern
Journal:  Cogn Behav Neurol       Date:  2006-09       Impact factor: 1.600

7.  Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease.

Authors:  E Salmon; F Collette; C Degueldre; C Lemaire; G Franck
Journal:  Hum Brain Mapp       Date:  2000-05       Impact factor: 5.038

8.  Trajectories of cognitive decline in Alzheimer's disease.

Authors:  Patricia A Wilkosz; Howard J Seltman; Bernie Devlin; Elise A Weamer; Oscar L Lopez; Steven T DeKosky; Robert A Sweet
Journal:  Int Psychogeriatr       Date:  2009-09-28       Impact factor: 3.878

9.  The effect of education on rCBF changes in Alzheimer's disease: a longitudinal SPECT study.

Authors:  Haruo Hanyu; Tomohiko Sato; Soichiro Shimizu; Hidekazu Kanetaka; Toshihiko Iwamoto; Kiyoshi Koizumi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-12       Impact factor: 9.236

10.  Objective metamemory testing captures awareness of deficit in Alzheimer's disease.

Authors:  Stephanie Cosentino; Janet Metcalfe; Brady Butterfield; Yaakov Stern
Journal:  Cortex       Date:  2007-10       Impact factor: 4.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.